Jonsson Comprehensive Cancer Center

This study tests two drugs, imlunestrant and abemaciclib, in people with ER+ breast cancer who have small amounts of tumor DNA still in their blood after initial treatment. The goal is to see if this combination can clear those remaining cancer traces and prevent the cancer from …

This study tests whether adding the drug zipalertinib to standard chemotherapy can shrink tumors more effectively before surgery in people with a specific type of lung cancer (EGFR-mutant non-small cell lung cancer). About 16 adults with stage II-IIIB cancer that can be removed w…

This study tests a drug called ropeginterferon alfa-2b, a long-acting immune protein, in 35 adults with rare blood cancers like chronic myelomonocytic leukemia (CMML). The goal is to see if it can safely slow or stop cancer growth. Participants will receive the drug and be monito…

This study tests whether a special MRI technique (CEST) can help surgeons see and remove more glioblastoma tissue than standard surgery. About 60 adults with newly diagnosed glioblastoma will be randomly assigned to either CEST-guided surgery or standard surgery. The goal is to s…

This study is testing a more precise form of radiation therapy for prostate cancer. It aims to control the cancer while trying to reduce the common side effects that can affect urinary and sexual function. The trial will enroll 45 men with early-stage prostate cancer to see if th…

This study tests a small, portable wound vacuum device (SNaP) to see if it helps surgical wounds on the lower legs heal faster after skin cancer removal. About 60 adults aged 19-79 who have had Mohs surgery for non-melanoma skin cancer will either use the device or receive standa…

This study tests whether a personalized, supervised exercise program done at home can improve physical function in people who have finished treatment for gastroesophageal cancer. The program includes aerobic and resistance exercises tailored to each person. The goal is to see if …

This study follows 72 adults with early-stage gastroesophageal cancer to see how their physical function changes during chemotherapy. Participants will complete simple physical tests and surveys before, during, and after treatment. The goal is to better understand which patients …